Cubist Pharmaceuticals

Cubist Pharmaceuticals is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products to address unmet medical needs in acute care settings. The company markets CUBICIN (daptomycin for injection), the first antibiotic in a new class of antimicrobial agents known as lipopeptides in the United States.